Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD Election
AAD governance
Support AAD
AAD Help Center
2025 Annual Meeting
2025 Innovation Academy
2026 Annual Meeting
Academy meetings archive
Professional education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Contact PM staff
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Job board
Join or sell a practice
Burnout & wellness
Career launch
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

American Academy of Dermatology statement on Benzoyl Peroxide in OTC Personal Care Products

American Academy of Dermatology President Susan C. Taylor, MD, FAAD

ROSEMONT, Ill. (March 24, 2025) — Recent reports have noted that benzoyl peroxide, a common acne-fighting ingredient available by prescription and over the counter, has the potential to break down into benzene. The American Academy of Dermatology is committed to providing the public with science-based information to help them make informed decisions about their skin, hair and nail health.

Research on this issue is ongoing, and we continue to monitor new findings to ensure dermatologists and patients have the most accurate and up-to-date information. The FDA recently tested 95 benzoyl peroxide acne products for benzene contamination, finding that over 90% had undetectable or extremely low levels, while a small number contained elevated levels, leading to voluntary recalls by a handful of companies. While some studies suggest potential connections between benzene and an elevated risk for certain diseases, like cancer, the potential risk is still being investigated.

If you have one of the recalled products listed on the FDA website, there is no immediate cause for concern. This is a retail-level recall, meaning stores and online retailers have been asked to stop selling these products. The FDA has not recommended that the public take any action at this time.

The Academy recommends that patients follow best practices for storing and handling products containing benzoyl peroxide and consult their dermatologist if they have any concerns. To minimize risk:

  • Store products according to the manufacturer’s instructions at room temperature or cooler conditions (e.g. refrigerated).

  • Replace products that contain benzoyl peroxide every 10-12 weeks.

  • Benzoyl peroxide products should be discarded if exposed to high temperatures (e.g. greater than 78°F).

The Academy remains dedicated to patient safety and will update our guidance as new, high-quality research becomes available. If you are concerned about using acne products containing benzoyl peroxide, opt for other options such as topical retinoids, salicylic acid, or azelaic acid, or speak with a board-certified dermatologist.

# # #

Contact

Shelby Homiston, shomiston@aad.org

Rhys Saunders, rsaunders@aad.org

Media Relations, mediarelations@aad.org

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 21,800 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on  Facebook, TikTok, Pinterest, and YouTube, and @AADskin1 on Instagram.